From a mixture of substances formed by producing strains of Streptomyces aureofaciens under conditions of submerged fermentation a new metabolite, ekatetrone, was isolated.
Its isolation and basic physical and chemical data are described. Ekatetrone is a quinone derivative with a carboxamide group.
In tests in vitro with cells of EHRLICH'S ascites tumour evidence was provided that ekatetrone inhibits proteo-and nucleosynthesis.
Investigations of metabolites of Streptomyces aureofaciens strains were conducted in particular by MCCORMICK et al.') For the biosynthesis of tetracyclines there is experimental evidence for the stages following the production of 6-methylpretetramide2), i.e. after closure of the linear hypothetical nonaketide. None of the assumed metabolites of the preceding stages of the biosynthetic pathway has been hitherto isolated. Simpler substances, such as trans-2,3-dihydro-3-hydroxyanthranilic acid isolated from a strain of Streptomyces aureofaciens3', or aromatic derivatives from a mutant strain of Streptomyces rimosus'), obviously are in no direct relationship with the biosynthesis of tetracyclines. Among substances simpler than pretetramides, which are themselves proven members of the biosynthetic pathway of tetracyclines, so far two have been described, protetrone5 l and its methylanthrone analogue'). These two substances are, however, not on the main metabolic pathway. They are shunt metabolites with an open ring A of the molecule of pretetramide. It is also possible that the hypothetical nonaketide is closed to form an anthracene derivative and only in a subsequent step aromatization takes place and pretetramide is formed''. The mycelium (1 kg wet weight) after filtration of the culture of the strain Streptomyces aureofaciens 84/54 from the reciprocal shaker (200 flasks; 11.5 liters), acidified to pH 2.5 with oxalic acid, was extracted with methanol (2 x 1.5 liters) at 40°C. The methanolic extracts were combined and evaporated in vacuum at a temperature of 40°C to a volume of ca. 200 ml. From the concentrate the mixture of metabolites was precipitated by addition of petroleum ether (400 ml). The separated precipitate (3.8 g) was triturated with methylisobutyl ketone (150 ml); the undissolved residue was filtered off and the filtrate was applied to a polyamide column (3 x 34 cm; 100 g; Chemical Works Ruzomberok).
The column was developed with methylisobutyl ketone and fractions of 20 ml were collected. Fractions 59-61 after about 5 hours standing at laboratory temperature crystallized and by recrystallization from acetic acid we obtained a chromatographically uniform preparation of ekatetrone (4.9 mg).
The fermentation medium (600 liters) after cultivation of strain Streptomyces aureofaciens 1717
in the fermenter was acidified with hydrochloric acid to pH 2.0. The mycelium was separated and washed with distilled water. The mycelium (50 kg wet weight) was extracted with ethyl acetate (3 x 33 liters) for one hour at laboratory temperature under constant stirring. The ethyl acetate extracts after filtering were combined and evaporated at 35°C in a vacuum evaporator to a volume of 4.1 liters. By addition of petroleum ether (5 liters) to this concentrate the mixture of metabolites was precipitated (60 g), and after filtration it was dissolved in methanol (1.2 liters). Ekatetrone was isolated from the mixture by column chromatography on polyamide (0.5 kg; 8 x 25 cm). To the column 150 ml of the methanolic solution (7.5 g of the mixture of substances) were applied. The column was developed with methanol and fractions of 50 ml were collected. From the combined yellow fractions 3 and 4 after brief standing at laboratory temperature ekatetrone crystallized as yellow needles (15.4 mg). The chromatographic behaviour of ekatetrone is described in Table 1 . The ultraviolet and visible spectra of ekatetrone (Fig. 1) show absorption maxima A,,,a. The interpretation of all the above characteristics suggests that ekatetrone is a quinone substance with a carboxamide group. It differs from protetrone and its methyl anthrone analogues'". The structure determination of ekatetrone is described in a subsequent papery'. 
Discussion
The presence of ekatetrone as an accompanying minor substance was proved only in producing strains of Streptomyces aureofaciens under conditions optimal for tetracycline formation (2,500-4,100 1 cg/ml at the 96th hour of fermentation).
In low-producing strains (maximum tetracycline production 300 /tg/ml) and non-producing strains ekatetrone was not detected. Typically, ekatetrone was found only in the final stages of fermentation.
From these experimental data we may suggest a possible biogenetic position of ekatetrone. If the rate of synthesis of the basic building units (malonyl CoA) is higher than the rate of the synthesis of intermediary products in the main metabolic pathway leading to tetracyclines, the excess of precursors is diverted to metabolic side-pathways').
This may be the 
